Precision Data Guides Precision Medical Interventions; Reduces CAUTI Risk
Northfield, Ill. Jan. 23, 2017 — Medline Industries, Inc., a leading global healthcare manufacturer and distributor, and Potrero Medical, Inc., a privately held medical device company and the developer of the Accuryn™ critical care monitoring system, today announced a joint partnership to expand commercialization and continue clinical investigations to further support the benefits of the Accuryn critical care monitoring system. With this agreement, Medline has secured long-term exclusivity for marketing and distribution of Accuryn in North America. The ability to leverage Medline’s extensive reach in the acute care hospital market ensures that as many critical care physicians and nurses as possible will have access to this state-of-the-art system that empowers clinicians with more accurate and easily accessible data.
“We are pleased to partner with Medline to commercialize the world’s only technology capable of providing accurate, real-time data related to urine production and intra-abdominal pressure – the Accuryn Monitoring System.” says Dr. Daniel Burnett, chief executive officer of Potrero Medical. “Medline’s reputation as a market leader combined with their impressive customer base will quickly make the Accuryn critical care monitoring system available to thousands of hospital systems and millions of patients in the United States.”
“Medline is committed to being the leading supplier of clinically innovative solutions to healthcare providers. Our partnership with Potrero Medical on the Accuryn Monitoring System fully demonstrates this commitment and sets the pace for a new standard in critical care monitoring. We look forward to presenting this new technology to leading intensivists and critical care nurses at this month’s Society of Critical Care Medicine Annual Congress,” says David Greenberg, executive vice president of strategy and group president, Medline.
About the Accuryn System
Accuryn is a critical care monitoring system that transforms the traditional urinary catheter into a next-generation diagnostic tool. Accuryn uses proprietary electromechanical designs and advanced software algorithms to deliver automated, real-time actionable data including urine output, core body temperature and intra-abdominal pressure (IAP). The IAP measurement is taken directly from the catheter tip with just a push of a button, reducing setup time, potential errors, and infection risk. Additionally, innovative active drain line clearance overcomes urine drainage issues that can make urine output measurements unreliable.
The Accuryn™ System is a 510(k) cleared medical device available for sale in the United States.
For more information on Accuryn, visit www.AccurynFromMedline.com?cmpid=RID:MN:Accuryn:1/23/2017.
Medline is a global manufacturer and distributor serving the healthcare industry with medical supplies and clinical solutions that help customers achieve both clinical and financial success. Headquartered in Northfield, Ill., the company offers 350,000+ medical devices and support services through more than 1,200 direct sales representatives who are dedicated points of contact for customers across the continuum of care. For more information on Medline, go to www.medline.com or http://www.medline.com/social-media to connect with Medline on its social media channels.
About Potrero Medical, Inc.
Potrero Medical, Inc., the latest spinout of medical device incubator Theranova, LLC, is headquartered in San Francisco, CA and was founded with a mission to improve outcomes, reduce costs and expand access to healthcare. For more information about the company, please visit www.potreromed.com.